A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.

Xu Shan Sun, Christian Sire, Yungan Tao, Laurent Martin, Marc Alfonsi, Jean Briac Prevost, Michel Rives, Cedrik Lafond, Jean-Marc Tourani, Julian Biau, Lionnel Geoffrois, Alexandre Coutte, Xavier Liem, Elodie Vauleon, Franck Drouet, Jean-François Ramee, Gabriel Waksi, Laura Sinigaglia, Anne Auperin, Jean Bourhis

J Clin Oncol 36, 2018 (suppl; abstr 6018)